Lamotrigine is one of the safest anti-seizure medications to use during pregnancy. Among all the options available for epilepsy and bipolar disorder, it consistently shows one of the lowest rates of birth defects, and most major medical guidelines consider it a preferred choice for women who need continued treatment. That said, pregnancy changes how your body processes the drug, so staying on it safely requires active monitoring and dose adjustments throughout.
Birth Defect Risk Compared to Background Rates
The general population risk of a major birth defect is roughly 2 to 3%. In a study of 490 pregnancies exposed to lamotrigine alone, the malformation rate was 4.49%, compared to 3.27% in women with epilepsy who took no medication. That difference was not statistically significant, meaning it could easily be explained by chance or by epilepsy itself rather than the drug. A separate large registry found an even lower rate of 1.9% for lamotrigine monotherapy.
The picture changes if lamotrigine is combined with valproate. That specific combination raised the malformation rate to 9.1% in one study, roughly five times higher than lamotrigine alone. The elevated risk appears driven by valproate, which is well established as the most harmful anti-seizure drug in pregnancy. If you’re currently taking both, that’s a conversation to have with your prescriber before conception if possible.
The Oral Cleft Question
Early data from a North American pregnancy registry raised concern about a possible link between lamotrigine and cleft lip or palate. This triggered years of follow-up research. A 2025 meta-analysis pooling eight studies found an initial signal of increased risk (about 1.4 times the baseline rate), but that association disappeared entirely when researchers looked only at higher-quality cohort studies or studies that properly adjusted for other variables like smoking, other medications, and maternal health conditions. The authors concluded that lamotrigine does not increase the risk of oral clefts. The original drug manufacturer’s registry also found no increased risk of facial clefts in its final report.
Long-Term Effects on Child Development
Beyond physical birth defects, many parents worry about cognitive development. The data here is largely reassuring. A systematic review found that children exposed to lamotrigine in the womb scored somewhat lower on cognitive tests before age 3, but this gap closed as they got older. In one study tracking children from ages 2 through 6, IQ scores in the lamotrigine group improved steadily over time and were not significantly different from unexposed children by school age.
There’s no established link to autism. A meta-analysis covering over 5,000 exposed children and 33,000 unexposed children found no statistically significant association between prenatal lamotrigine exposure and autism spectrum disorder. One earlier network analysis suggested a possible link to autism traits, but this has not held up in studies using untreated comparison groups.
How Pregnancy Changes Drug Levels
This is the part that catches many women off guard. Your body clears lamotrigine much faster during pregnancy, which means blood levels can drop significantly, potentially leading to breakthrough seizures. In about 77% of women, the rate at which the body eliminates lamotrigine triples by the third trimester, with clearance increasing by roughly 76% by the end of the first trimester, 153% by the second, and 219% by the third. The remaining 23% of women experience only modest changes of around 20%.
Because of this variability, blood level monitoring every one to three months during pregnancy is standard practice. The goal is to keep your levels close to whatever baseline was established before pregnancy. If your levels drop, your dose will need to go up, sometimes substantially. Some clinicians recommend establishing a baseline level before conception so there’s a clear target to maintain.
What Happens After Delivery
After birth, your body’s ability to clear lamotrigine returns to normal remarkably fast, with a half-life of just about four days. This means that if your dose was increased during pregnancy, it needs to come back down quickly to avoid toxicity. Signs of too-high levels include dizziness, double vision, and nausea. Your prescriber should have a tapering plan ready before your due date.
Folic Acid Before and During Pregnancy
UK guidelines recommend that women taking any anti-seizure medication take 5 mg of folic acid daily, starting before conception and continuing through the first trimester. This is ten times the standard prenatal dose of 0.4 to 0.8 mg. One study found a significantly higher malformation rate among lamotrigine-exposed pregnancies where mothers took less than 5 mg per day. High-dose folic acid is available by prescription and is a simple step that may meaningfully reduce risk.
Breastfeeding on Lamotrigine
Lamotrigine does pass into breast milk, and infant blood levels tend to be notable. Across multiple studies, breastfed infants had blood concentrations averaging 25 to 35% of their mother’s levels, with some individual infants reaching as high as 50% or even 90% in one large multicenter study. In terms of actual dose, exclusively breastfed infants receive roughly 9% of the maternal weight-adjusted dose through milk.
Despite these relatively high transfer rates, serious adverse effects in breastfed infants have been rare in published data. Most experts consider breastfeeding compatible with lamotrigine use, though monitoring the infant for unusual sleepiness, poor feeding, or rash is reasonable, especially in the first few weeks when infant blood levels tend to be highest. By two months, levels in partially breastfed infants drop to around 20 to 23% of maternal concentrations.
Monotherapy Matters
The clearest takeaway from the research is that lamotrigine alone carries a much more favorable safety profile than lamotrigine combined with other medications, particularly valproate. If you’re on a combination regimen and planning a pregnancy, simplifying to lamotrigine monotherapy before conception, when possible, significantly reduces risk. This kind of medication adjustment takes time and should ideally happen well before pregnancy, since abrupt changes can trigger seizures or mood episodes.